Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A known ✓ | Q03164 | 3/20 | 0.34 |
| ▸ | MEN1 known ✓ | O00255 | 2/20 | 0.33 |
| ▸ | FKBP1A | P62942 | 6/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9344131 | 0.86 | SMN1; SMN2 (0.43) | FKBP1ASMN1; SMN2KMT2APOLBTSHR | |
| Fumaric Acid SCHEMBL9346156 | 0.80 | MAPT (0.39) | SMN1; SMN2KMT2ATSHRMEN1CYP3A4 | |
| Fumaric Acid SCHEMBL9346169 | 0.79 | ITGB3 (0.42) | TSHRCYP3A4LMNA | |
| Fumaric Acid SCHEMBL9345013 | 0.75 | GNAI3 (0.48) | SMN1; SMN2POLBTSHRALOX15CYP3A4 | |
| SCHEMBL9329947 | 0.74 | MEN1 (0.35) | KMT2ATSHRALOX15MEN1CYP2C9 | |
| Fumaric Acid SCHEMBL9344124 | 0.74 | CYP3A4 (0.44) | SMN1; SMN2KMT2ATSHRCYP3A4LMNA | |
| Fumaric Acid SCHEMBL9345070 | 0.73 | ALDH1A1 (0.44) | SMN1; SMN2KMT2ATSHRMEN1CYP3A4 | |
| SCHEMBL3834072 | 0.73 | KDM4E (0.48) | KMT2APOLBTSHRALOX15MEN1 | |
| Fumaric Acid SCHEMBL9344920 | 0.73 | PRCP (0.46) | SMN1; SMN2KMT2AALOX15MEN1CYP3A4 | |
| SCHEMBL9345022 | 0.72 | POLB (0.38) | FKBP1ASMN1; SMN2KMT2APOLBCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5280031-A | Cyclic azaaliphatic compounds with a nitroxy function, processes for the preparation thereof and pharmaceutical compositions containing them | BOEHRINGER MANNHEIM GMBH (DE) | 1994-01-18 | — | — | US | disclosed |